Beta Pharmaceuticals Selected in 2022 Jiangsu Province Science and Technology Enterprises "Listed Cultivation Library"
Release time:
2023-02-28
October 2022,JiangsuThe Provincial Science and Technology Department and Jiangsu Securities Regulatory Bureau jointly issuedThe 2022 provincial science and technology enterprise listing and cultivation plan list of enterprises, a totalIncludeWUXI BETA PHARMACEUTICAL TECHNOLOGY CO., LTDwithin141 companies were selected.
Wuxi Beta Pharmaceutical Technology Co., Ltd., isChinaSpecializing in carbon in the field of nuclear technology applications-14（C14）,Carbon-13(C13) and other isotope labeling products and tracer technology research and development and industrialization.High-tech enterprises.The company focuses on the global shortage.C14 isotope, to create a unique "C14 irradiation target material-C14 source material-C14 key precursor compound-C14 labeling service-C14 nuclear drug bulk drug-C14 nuclear drug preparation-C14 waste treatment" of the whole industrial chain,CommittedintoLongForChinaC14Field LeaderEnterprise,InternationalC14 leading enterprises in the field.To date has beenMore than 100 listed companies, leading companies, industry rookies, scientific research institutes, etc. have marked nearly 200 innovative pharmaceutical and pesticide compounds, and none of the projects have failed. In one fell swoop, it broke the situation that my country's C14 mark has to be done abroad and has been widely praised by the industry., It has strongly promoted the research and development process of China's innovative pharmaceuticals and pesticides. On January 29, 2023, Beta Pharmaceuticals provided C14 labeling services to listed company Junshi Bio for the treatment of new coronavirus infection of a class 1 innovative drug-deuterium hydrobromide Remidovir tablets (trade name: Mindevi) was awarded the State Food and Drug Administration.attached conditionApproved for listing.In August 2022,Beta MedicineFirst export to US pharmaceutical giantC14 Key Precursor Compounds,Realized ChinaThe breakthrough of zero export of C14 key precursor compounds has also opened up the path for C14 marked products to be exported to overseas markets.
The listing and cultivation plan of science and technology enterprises in Jiangsu Province focuses on high-tech enterprises, and carefully selects a number of high-growth science and technology enterprises with perfect governance structure, outstanding main business, strong competitiveness and development potential, aiming to smooth the listing channels of high-tech enterprises and integrate multi-party high-quality resources to provide warehousing enterprisesProfessional precision guidance, to promote the effective docking of enterprises and multi-level capital market. The scientific and technological enterprises cultivated in the warehouse have become an important source of listed enterprises in Jiangsu..
Related News
Tel.：0510-81695383
E-mail：chengcaihong@beitalab.com
Fax：0510-81602153
Add：70 Dongsheng West Road, Jiangyin City, Jiangsu Province
Postal Code: 214437
Copyright©2024 Wuxi Beita Pharmatech Co., Ltd. Business License
